Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
22.84
-0.07 (-0.31%)
At close: Dec 5, 2025, 4:00 PM EST
22.87
+0.03 (0.13%)
After-hours: Dec 5, 2025, 5:28 PM EST
Immunovant Market Cap
Immunovant has a market cap or net worth of $4 billion as of December 5, 2025. Its market cap has increased by 8.14% in one year.
Market Cap
4.00B
Enterprise Value
3.48B
1-Year Change
8.14%
Ranking
Category
Stock Price
$22.84
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $4.00B, an increase of 3,118.75%. That is a compound annual growth rate of 71.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 4.00B | 10.11% |
| Dec 31, 2024 | 3.64B | -40.34% |
| Dec 29, 2023 | 6.09B | 165.79% |
| Dec 30, 2022 | 2.29B | 134.03% |
| Dec 31, 2021 | 979.80M | -78.33% |
| Dec 31, 2020 | 4.52B | 404.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |